|
Market Closed -
Toronto S.E.
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 3.870 CAD | -0.51% |
|
-3.73% | -19.71% |
| 09-24 | HLS Therapeutics Gets TSX Acceptance to Increase Normal Course Issuer Bid | MT |
| 08-12 | HLS Therapeutics Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLS THERAPEUTICS INC. | Pharmaceuticals Wholesale | -0.51% | -3.73% | -19.71% | -29.89% | -78.79% | 82.64M |  | |  |
- Stock Market
- Stocks
- HLS Stock
- Charts HLS Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
